A 64-year-old male with a history of cirrhosis due to viral hepatitis C was successfully treated with DAAs. During surveillance a hypervascular tumour (largest diameter 3.5 cm) with wash-out in the portal phase was detected in the left lobe. At the liver tumour board meeting the multidisciplinary team evaluated the patient based on a multi-parametric composite assessment of liver function, portal hypertension, extent of hepatectomy, expected volume of the future liver remnant, performance status and patients’ co-morbidities.

The tumour board suggested a liver resection of the involved segment. When informing the patient, he asks about the risk of morbidity and mortality.